• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈侧区淋巴结转移(N1b)是甲状腺乳头状癌预后的另一个危险因素。

Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.

机构信息

Endocrinology, Department of Clinical and Experimental Medicine, University of Catania, Garibaldi-Nesima Medical Center, Via Palermo 636, 95122, Catania, Italy.

Infectious Disease, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.

出版信息

J Endocrinol Invest. 2017 Dec;40(12):1355-1363. doi: 10.1007/s40618-017-0714-y. Epub 2017 Jun 23.

DOI:10.1007/s40618-017-0714-y
PMID:28646475
Abstract

PURPOSE

Papillary thyroid carcinoma (PTC), the most common thyroid cancer histotype, has a good prognosis even when spread to the neck lymph node (LN). The prognostic role of LN metastases' location is still controversial. The aim of the present study was to evaluate the clinical relevance of the number and location of LN metastases at presentation in PTCs.

METHODS

This retrospective study included a consecutive series of 1653 PTC patients followed for a mean period of 5.9 years in a referral thyroid cancer clinic. All patients have undergone thyroidectomy with the dissection of at least six LNs. According to the LN status, patients were subdivided into 569 N0 (34.4%), 644 N1a (39.0%, central compartment) and 440 N1b (26.6%, latero-cervical compartment).

RESULTS

Age at diagnosis was significantly lower in N1b (39.8, IQR 30.7-51.6) and N1a (40.1, IQR 31.3-50.1) than in N0 (44.7, IQR 36.6-55.0 yrs). The male gender was more prevalent in N1b than in N1a and N0 (F/M = 1.9/1, 4.0/1 and 5.5/1, respectively). Persistent/recurrent disease at last control was significantly more frequent in N1b (29.8%) than in N1a (14.3%), and in N1a than in N0 (4.2%) (p < 0.01 for all). Also, distant metastases were significantly (p < 0.001) more frequent in N1b (14.1%) than in N1a (4.3%) and N0 (1.6%). LN metastases' number (>5) was a significant risk factor for persistent/recurrent disease only for N1a patients.

CONCLUSIONS

These data indicate that persistent/recurrent disease and distant metastases are significantly more frequent in patients with latero-cervical LN (N1b) metastases and that the LN location should be used for a better postsurgical risk stratification.

摘要

目的

甲状腺乳头状癌(PTC)是最常见的甲状腺癌组织学类型,即使转移到颈部淋巴结(LN),其预后也较好。LN 转移部位的预后作用仍存在争议。本研究旨在评估 PTC 患者就诊时 LN 转移数量和位置的临床相关性。

方法

本回顾性研究纳入了在甲状腺癌诊所连续就诊的 1653 例 PTC 患者,平均随访时间为 5.9 年。所有患者均接受甲状腺切除术,并至少清扫 6 枚 LN。根据 LN 状态,患者分为 569 例 N0(34.4%,中央区)、644 例 N1a(39.0%,中央区)和 440 例 N1b(26.6%,颈侧区)。

结果

N1b(39.8,IQR 30.7-51.6)和 N1a(40.1,IQR 31.3-50.1)患者的诊断年龄明显低于 N0(44.7,IQR 36.6-55.0 岁)。N1b 患者的男性比例明显高于 N1a 和 N0(男女比分别为 1.9/1、4.0/1 和 5.5/1)。N1b 患者持续性/复发性疾病的比例(29.8%)明显高于 N1a(14.3%)和 N0(4.2%)(均 P<0.01)。此外,N1b 患者远处转移的比例(14.1%)明显高于 N1a(4.3%)和 N0(1.6%)(均 P<0.001)。仅 N1a 患者的 LN 转移数量(>5 枚)是持续性/复发性疾病的显著危险因素。

结论

这些数据表明,颈侧区 LN(N1b)转移患者持续性/复发性疾病和远处转移的比例明显更高,LN 位置应用于更好的术后风险分层。

相似文献

1
Latero-cervical lymph node metastases (N1b) represent an additional risk factor for papillary thyroid cancer outcome.颈侧区淋巴结转移(N1b)是甲状腺乳头状癌预后的另一个危险因素。
J Endocrinol Invest. 2017 Dec;40(12):1355-1363. doi: 10.1007/s40618-017-0714-y. Epub 2017 Jun 23.
2
Lymph node location is a risk factor for papillary thyroid cancer-related death.淋巴结位置是影响甲状腺乳头状癌相关死亡的风险因素。
J Endocrinol Invest. 2018 Nov;41(11):1349-1353. doi: 10.1007/s40618-018-0865-5. Epub 2018 Mar 16.
3
Prophylactic lymph node dissection in papillary thyroid carcinoma: is there a place for lateral neck dissection?甲状腺乳头状癌预防性淋巴结清扫术:是否需要行侧颈部淋巴结清扫术?
World J Surg. 2013 Jul;37(7):1584-91. doi: 10.1007/s00268-013-2020-y.
4
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.病理 N1a 期甲状腺乳头状癌中转移淋巴结比率和最大转移肿瘤大小的预后价值。
Eur J Endocrinol. 2013 Jan 17;168(2):219-25. doi: 10.1530/EJE-12-0744. Print 2013 Feb.
5
Correlation between the number of lymph node metastases and lung metastasis in papillary thyroid cancer.甲状腺乳头状癌中淋巴结转移数与肺转移的相关性。
J Clin Endocrinol Metab. 2012 Dec;97(12):4375-82. doi: 10.1210/jc.2012-1257. Epub 2012 Sep 27.
6
Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.伴有侧颈淋巴结转移的甲状腺乳头状癌复发:预测因素及手术治疗
Surgery. 2016 Mar;159(3):755-62. doi: 10.1016/j.surg.2015.08.033. Epub 2015 Oct 2.
7
Risk factors for recurrent disease in small papillary thyroid cancers - a Swedish register-based study.小乳头状甲状腺癌复发的风险因素 - 一项瑞典基于登记的研究。
Langenbecks Arch Surg. 2023 Apr 26;408(1):162. doi: 10.1007/s00423-023-02905-5.
8
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌区域淋巴结转移的结外扩展的预后意义
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.
9
Effect of skip metastasis to lateral neck lymph nodes on outcome of patients with papillary thyroid carcinoma.颈侧区跳跃转移对甲状腺乳头状癌患者预后的影响。
Langenbecks Arch Surg. 2022 Nov;407(7):3025-3030. doi: 10.1007/s00423-022-02604-7. Epub 2022 Jul 12.
10
Lateral cervical lymph node metastases in papillary thyroid cancer: a systematic review of imaging-guided and prophylactic removal of the lateral compartment.甲状腺乳头状癌颈侧区淋巴结转移:颈侧区影像学引导下和预防性清扫的系统评价。
Clin Endocrinol (Oxf). 2012 Jul;77(1):126-31. doi: 10.1111/j.1365-2265.2012.04336.x.

引用本文的文献

1
Is it possible to rule out level II and level VB dissection in patients with metastatic papillary thyroid cancer?对于转移性乳头状甲状腺癌患者,是否有可能排除II级和VB级淋巴结清扫?
Front Endocrinol (Lausanne). 2025 Aug 11;16:1520539. doi: 10.3389/fendo.2025.1520539. eCollection 2025.
2
Predictive factors for failure in patients with N1b papillary thyroid carcinoma.N1b 型甲状腺乳头状癌患者治疗失败的预测因素。
World J Surg Oncol. 2025 Jul 31;23(1):307. doi: 10.1186/s12957-025-03694-5.
3
FNA-Tg improves the diagnostic efficacy of FNAC for PTC lateral cervical LN metastasis.

本文引用的文献

1
Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients.分化型甲状腺癌患者放射性碘甲状腺消融指征的重新评估
J Endocrinol Invest. 2016 Oct;39(10):1087-94. doi: 10.1007/s40618-016-0503-z. Epub 2016 Jun 27.
2
Metastatic Lymph Node Ratio of Central Neck Compartment Has Predictive Values for Locoregional Recurrence in Papillary Thyroid Microcarcinoma.中央区颈部转移淋巴结比例对甲状腺微小乳头状癌局部区域复发具有预测价值。
Clin Exp Otorhinolaryngol. 2016 Mar;9(1):75-9. doi: 10.21053/ceo.2016.9.1.75. Epub 2016 Mar 7.
3
Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.
细针穿刺抽吸活检联合甲状腺球蛋白检测可提高细针穿刺抽吸活检对甲状腺乳头状癌侧颈淋巴结转移的诊断效能。
Sci Rep. 2025 Apr 23;15(1):14057. doi: 10.1038/s41598-025-99169-4.
4
The application of a clinical-multimodal ultrasound radiomics model for predicting cervical lymph node metastasis of thyroid papillary carcinoma.一种用于预测甲状腺乳头状癌颈部淋巴结转移的临床多模态超声影像组学模型的应用
Front Oncol. 2025 Jan 17;14:1507953. doi: 10.3389/fonc.2024.1507953. eCollection 2024.
5
Pretreatment level of circulating tumor cells is associated with lymph node metastasis in papillary thyroid carcinoma patients with ≤ 55 years old.55岁及以下乳头状甲状腺癌患者的循环肿瘤细胞预处理水平与淋巴结转移相关。
World J Surg Oncol. 2025 Jan 29;23(1):29. doi: 10.1186/s12957-025-03670-z.
6
Characterization of microRNA-223-3p as a novel promoter of cell proliferation and invasion in papillary thyroid carcinoma.微小RNA-223-3p作为甲状腺乳头状癌中细胞增殖和侵袭新启动子的特征分析
J Cell Commun Signal. 2024 Dec 19;19(1):e12057. doi: 10.1002/ccs3.12057. eCollection 2025 Mar.
7
Evaluating the efficacy of the endoscopic thyroidectomy via sternocleidomastoid muscle posteroinferior approach in identifying occult lateral cervical lymph node metastasis.评估经胸锁乳突肌后下入路内镜甲状腺切除术在识别隐匿性侧颈淋巴结转移中的疗效。
Gland Surg. 2024 Nov 30;13(11):1986-1995. doi: 10.21037/gs-24-340. Epub 2024 Nov 26.
8
Single-center external validation and reconstruction of multiple predictive models for skip lateral lymph node metastasis in papillary thyroid carcinoma.单中心外部验证及多预测模型在甲状腺乳头状癌跳跃侧颈部淋巴结转移中的重建。
Front Endocrinol (Lausanne). 2024 Aug 23;15:1366679. doi: 10.3389/fendo.2024.1366679. eCollection 2024.
9
Risk factors analysis of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a retrospective study of 830 patients.甲状腺乳头状癌侧颈部淋巴结转移的危险因素分析:一项 830 例患者的回顾性研究。
World J Surg Oncol. 2024 Jun 21;22(1):162. doi: 10.1186/s12957-024-03455-w.
10
Interplay of metabolic dysfunction-associated fatty liver disease and papillary thyroid carcinoma: insights from a Chinese cohort.代谢功能障碍相关脂肪性肝病与甲状腺乳头状癌的相互作用:来自中国队列的研究结果。
J Endocrinol Invest. 2024 Dec;47(12):2943-2952. doi: 10.1007/s40618-024-02391-6. Epub 2024 May 24.
预测甲状腺乳头状癌复发的淋巴结比率的最佳临界值
Medicine (Baltimore). 2016 Feb;95(5):e2692. doi: 10.1097/MD.0000000000002692.
4
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
5
Recurrence of papillary thyroid carcinoma with lateral cervical node metastases: Predictive factors and operative management.伴有侧颈淋巴结转移的甲状腺乳头状癌复发:预测因素及手术治疗
Surgery. 2016 Mar;159(3):755-62. doi: 10.1016/j.surg.2015.08.033. Epub 2015 Oct 2.
6
Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology.分化型甲状腺癌术后甲状腺消融的建议:意大利内分泌学会2015年立场声明
J Endocrinol Invest. 2016 Mar;39(3):341-7. doi: 10.1007/s40618-015-0375-7. Epub 2015 Aug 12.
7
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.对于年龄小于 45 岁的甲状腺乳头状癌患者,淋巴结转移的存在和数量与生存受损有关。
J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.
8
Lateral Neck Lymph Node Characteristics Prognostic of Outcome in Patients with Clinically Evident N1b Papillary Thyroid Cancer.侧颈部淋巴结特征对临床确诊为N1b期乳头状甲状腺癌患者预后的预测价值
Ann Surg Oncol. 2015 Oct;22(11):3530-6. doi: 10.1245/s10434-015-4398-2. Epub 2015 Feb 10.
9
Size distribution of metastatic lymph nodes with extranodal extension in patients with papillary thyroid cancer: a pilot study.甲状腺乳头状癌患者伴有结外侵犯的转移性淋巴结大小分布:一项初步研究。
Thyroid. 2015 Feb;25(2):238-41. doi: 10.1089/thy.2014.0392. Epub 2014 Dec 17.
10
American Thyroid Association statement on preoperative imaging for thyroid cancer surgery.美国甲状腺协会关于甲状腺癌手术术前影像学检查的声明。
Thyroid. 2015 Jan;25(1):3-14. doi: 10.1089/thy.2014.0096.